Saudi Chemical CoSAU:2230 -0.12%79 Days Payable is 132.79 as of Mar. 2026, which is 1% below its 10-year median of 133.61. GuruFocus rates SAU:2230 with a GF Score™ of 79/100 and a GF Value™ of ﷼8.59 (Fairly Valued). The stock has 3 warning signs investors should review. Among 927 Drug Manufacturers companies, Saudi Chemical Co ranks better than 69.69% on this metric.
The historical rank and industry rank for Saudi Chemical Co's Days Payable or its related term are showing as below:
SAU:2230'
s Days Payable Range Over the Past 10 Years
Min: 110.91 Med: 133.61 Max: 200.03
Current: 131.06
During the past 13 years, Saudi Chemical Co's highest Days Payable was 200.03. The lowest was 110.91. And the median was 133.61.
SAU:2230's Days Payable is ranked better than 69.69% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs SAU:2230: 131.06
Saudi Chemical Co's Days Payable
declined
from Mar. 2025 (137.16) to Mar. 2026 (132.79).
It may suggest that Saudi Chemical Coaccelerated paying its suppliers.
Saudi Chemical Co Days Payable Related Terms
Saudi Chemical Co Days Payable Historical Data
* Premium members only.
The historical data trend for Saudi Chemical Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:2230 vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Saudi Chemical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saudi Chemical Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Saudi Chemical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Saudi Chemical Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Saudi Chemical Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saudi Chemical Co (SAU:2230) has a Days Payable of 132.79 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Saudi Chemical Co and its competitors. This is near median its historical median of 133.61. Over the past decade, Saudi Chemical Co's Days Payable has ranged from 110.91 to 200.03. According to the industry distribution chart, Saudi Chemical Co ranks #281 out of 927 companies in the Drug Manufacturers industry, placing it in the top 30.3%.
Is Saudi Chemical Co's Days Payable too high?
Saudi Chemical Co's current Days Payable of 132.79 is near median its 10-year median of 133.61. Over the past 10 years, this metric has ranged from a low of 110.91 to a high of 200.03. The Drug Manufacturers industry median Days Payable is 90.38. Saudi Chemical Co's value of 132.79 is 46.9% above this industry median. Based on the distribution chart, Saudi Chemical Co ranks #281 out of 927 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Saudi Chemical Co has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Saudi Chemical Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Saudi Chemical Co ranks #281 out of 927 companies for Days Payable. This puts Saudi Chemical Co in the upper half of its industry. The industry median Days Payable is 90.38. Saudi Chemical Co's value of 132.79 is 46.9% above this benchmark. Historically, Saudi Chemical Co's own Days Payable has ranged from 110.91 to 200.03 over the past decade. While the company's 10-year median is 133.61 vs. the industry median of 90.38, Saudi Chemical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Saudi Chemical Co's current Days Payable of 132.79 is 46.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Saudi Chemical Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saudi Chemical Co's current Days Payable is 132.79, which is near median its own 10-year median of 133.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saudi Chemical Co stock overvalued right now?
Based on GuruFocus' analysis, Saudi Chemical Co (SAU:2230) is currently considered Fairly Valued. The stock's GF Value™ is ﷼8.59, compared to a current price of ﷼8.29 — trading 3.5% below its estimated fair value. The current Days Payable is 132.79, which is near median its 10-year median of 133.61 and 46.9% above the Drug Manufacturers industry median of 90.38. Saudi Chemical Co's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Saudi Chemical Co (SAU:2230), the current Days Payable is 132.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Saudi Chemical Co (SAU:2230) Overvalued in 2026?
Based on GuruFocus' analysis, Saudi Chemical Co stock appears to be undervalued.
The current stock price of ﷼8.29 is trading 3.5% below its estimated GF Value™ of ﷼8.59.
GuruFocus considers Saudi Chemical Co to be Fairly Valued.
Key valuation signals for SAU:2230:
Days Payable: 132.79 (near median its 10-year median of 133.61)
GF Value™: ﷼8.59 vs. price of ﷼8.29 (3.5% below fair value)
Industry Position: 46.9% above the Drug Manufacturers median (#281 of 927)
No single metric tells the full story. See the SAU:2230 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Saudi Chemical Co, along with its subsidiaries, is engaged in the manufacturing and distribution of explosives and their derivatives. Its other business operations include providing technical support services in explosions, wholesale and retail trading in medicines, medical materials and syrups, pharmaceutical preparations, medical and surgical tools, and equipment, supplies of hospitals and medical centers, and the manufacture of ammonium nitrate. The company operates in three segments: Explosives, Medicines & medical supplies, and Production of Ammonium Nitrate. It generates the majority of its revenue from Medicines & medical supplies.
79GF Score
Get the complete analysis for SAU:2230
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:2230 has been successfully added to your 
